Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets (2017 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Other Non-Current Assets of $93000.0 for Q1 2026, little changed on a QoQ basis from $93000.0 in Q4 2025, and down 88.7% year-over-year from $823000.0 in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $93000.0 for Q1 2026.
- Quarterly Other Non-Current Assets fell 88.7% year-over-year to $93000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93000.0 (down 88.7% YoY) and the FY2025 annual result came in at $93000.0, down 88.7% from the prior year.
- Other Non-Current Assets was $93000.0 for Q1 2026 at Aurinia Pharmaceuticals, roughly flat from $93000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $13.0 million in Q3 2022 and bottomed at $84000.0 in Q4 2022.
- A 5-year average of $2.8 million and a median of $867000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets slumped 99.29% — and 2023, when it jumped 1705.95%.
- Aurinia Pharmaceuticals' Other Non-Current Assets stood at $84000.0 in 2022, then soared by 1705.95% to $1.5 million in 2023, then tumbled by 45.75% to $823000.0 in 2024, then sank by 88.7% to $93000.0 in 2025, then changed by 0.0% to $93000.0 in 2026.
- Business Quant data shows AUPH's Other Non-Current Assets at $93000.0 in Q1 2026, $93000.0 in Q4 2025, and $93000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 93,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 823,000.00 |
| Dec 31, 2024 | 823,000.00 |
| Sep 30, 2024 | 868,000.00 |
| Jun 30, 2024 | 867,000.00 |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 13.05 Mn |
| Jun 30, 2022 | 12.36 Mn |
| Mar 31, 2022 | 11.84 Mn |
| Dec 31, 2021 | 11.84 Mn |
| Sep 30, 2021 | 11.84 Mn |
| Jun 30, 2021 | 11.86 Mn |